Obstructive sleep apnoea, cigarette smoking and plasma orexin-A in a sleep clinic cohort
Journal of International Medical Research, cilt.37, sa.2, ss.331-340, 2009 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 37 Sayı: 2
- Basım Tarihi: 2009
- Doi Numarası: 10.1177/147323000903700207
- Dergi Adı: Journal of International Medical Research
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.331-340
- Anahtar Kelimeler: OBSTRUCTIVE SLEEP APNOEA, OREXIN-A, CIGARETTE SMOKING, APNOEA-HYPOPNOEA INDEX
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Orexin-A is a neuropeptide involved in the regulation of food intake and the sleep-wake cyle. This study investigated plasma orexin-A levels in a sleep clinic cohort, adjusting for smoking habits, in 76 participants comprising 41 with obstructive sleep apnoea (OSA) (apnoea-hypopnoea index [AHI] 44.1 ± 19.1 events/h) and 35 without OSA (AHI 6.3 ± 4.7 events/h). Plasma orexin A levels were significantly lower in OSA patients (15.0 ± 4.6 ng/ml) compared with those without OSA (31.4 ± 6.5 ng/ml). In non-OSA subjects, there was no significant difference between never smokers and ex/current smokers in plasma orexin-A levels (32.9 ± 9.5 versus 29.7 ± 8.9 ng/ ml, respectively) whereas, in the OSA sub-group, orexin-A levels were significantly lower in never smokers than in ex/current smokers (4.0 ± 1.2 versus 21.4 ± 7.0 ng/ml). A significant inverse relationship was found between plasma orexin-A levels and AHI amongst never smokers, but there was no significant relationship amongst ex/ current smokers. These results confirm previous studies demonstrating lower levels of plasma orexin-A in OSA patients and indicate that smoking may affect orexin-A levels and AHI. Copyright © 2009 Field House Publishing LLP.